{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T06:53:59Z","timestamp":1793256839162,"version":"4.5.0"},"reference-count":49,"publisher":"American Society of Hematology","issue":"5","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2012,8,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Chronic lymphocytic leukemia (CLL) represents 30% of adult leukemia. TCL1 is expressed in \u223c 90% of human CLL. Transgenic expression of TCL1 in murine B cells (E\u03bc-TCL1) results in mouse CLL. Here we show for the first time that the previously unexplored endoplasmic reticulum (ER) stress response is aberrantly activated in E\u03bc-TCL1 mouse and human CLL. This includes activation of the IRE-1\/XBP-1 pathway and the transcriptionally up-regulated expression of Derlin-1, Derlin-2, BiP, GRP94, and PDI. TCL1 associates with the XBP-1 transcription factor, and causes the dysregulated expression of the transcription factors, Pax5, IRF4, and Blimp-1, and of the activation-induced cytidine deaminase. In addition, TCL1-overexpressing CLL cells manufacture a distinctly different BCR, as we detected increased expression of membrane-bound IgM and altered N-linked glycosylation of Ig\u03b1 and Ig\u03b2, which account for the hyperactive BCR in malignant CLL. To demonstrate that the ER stress-response pathway is a novel molecular target for the treatment of CLL, we blocked the IRE-1\/XBP-1 pathway using a novel inhibitor, and observed apoptosis and significantly stalled growth of CLL cells in vitro and in mice. These studies reveal an important role of TCL1 in activating the ER stress response in support for malignant progression of CLL.<\/jats:p>","DOI":"10.1182\/blood-2011-11-394346","type":"journal-article","created":{"date-parts":[[2012,6,13]],"date-time":"2012-06-13T05:31:58Z","timestamp":1339565518000},"page":"1027-1038","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":72,"title":["Overexpression of TCL1 activates the endoplasmic reticulum stress response: a novel mechanism of leukemic progression in mice"],"prefix":"10.1182","volume":"120","author":[{"given":"Crystina L.","family":"Kriss","sequence":"first","affiliation":[{"name":"Department of Immunology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier A.","family":"Pinilla-Ibarz","sequence":"additional","affiliation":[{"name":"Department of Immunology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL;"},{"name":"Department of Malignant Hematology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam W.","family":"Mailloux","sequence":"additional","affiliation":[{"name":"Department of Immunology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John J.","family":"Powers","sequence":"additional","affiliation":[{"name":"Department of Immunology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Hang Anthony","family":"Tang","sequence":"additional","affiliation":[{"name":"Department of Immunology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang Won","family":"Kang","sequence":"additional","affiliation":[{"name":"Drug Discovery Department, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Zanesi","sequence":"additional","affiliation":[{"name":"Department of Molecular Virology, Immunology and Medical Genetics, The Ohio State University School of Medicine, Columbus, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pearlie K.","family":"Epling-Burnette","sequence":"additional","affiliation":[{"name":"Department of Immunology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo M.","family":"Sotomayor","sequence":"additional","affiliation":[{"name":"Department of Immunology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL;"},{"name":"Department of Malignant Hematology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo M.","family":"Croce","sequence":"additional","affiliation":[{"name":"Department of Molecular Virology, Immunology and Medical Genetics, The Ohio State University School of Medicine, Columbus, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan R.","family":"Del Valle","sequence":"additional","affiliation":[{"name":"Drug Discovery Department, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Chi Andrew","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Immunology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"6","key":"2019111808225102000_B1","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1182\/blood.V94.6.1848","article-title":"Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia.","volume":"94","author":"Hamblin","year":"1999","journal-title":"Blood"},{"issue":"3","key":"2019111808225102000_B2","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1182\/blood-2007-07-099564","article-title":"Stereotyped patterns of somatic hypermutation in subsets of patients with chronic lymphocytic leukemia: implications for the role of antigen selection in leukemogenesis.","volume":"111","author":"Murray","year":"2008","journal-title":"Blood"},{"issue":"6","key":"2019111808225102000_B3","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.1182\/blood-2007-02-073130","article-title":"Nonstochastic pairing of immunoglobulin heavy and light chains expressed by chronic lymphocytic leukemia B cells is predicated on the heavy chain CDR3.","volume":"111","author":"Widhopf","year":"2008","journal-title":"Blood"},{"issue":"13","key":"2019111808225102000_B4","doi-asserted-by":"crossref","first-page":"4609","DOI":"10.1182\/blood-2002-06-1683","article-title":"Expression of ZAP-70 is associated with increased B-cell receptor signaling in chronic lymphocytic leukemia.","volume":"100","author":"Chen","year":"2002","journal-title":"Blood"},{"issue":"3","key":"2019111808225102000_B5","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1182\/blood-2002-06-1822","article-title":"Differential signaling via surface IgM is associated with VH gene mutational status and CD38 expression in chronic lymphocytic leukemia.","volume":"101","author":"Lanham","year":"2003","journal-title":"Blood"},{"issue":"6","key":"2019111808225102000_B6","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1182\/blood-2008-02-140673","article-title":"Toll-like receptors: lessons to learn from normal and malignant human B cells.","volume":"112","author":"Chiron","year":"2008","journal-title":"Blood"},{"issue":"10","key":"2019111808225102000_B7","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1080\/10428190903115410","article-title":"The role of toll-like receptors in chronic B-cell malignancies.","volume":"50","author":"Muzio","year":"2009","journal-title":"Leuk Lymphoma"},{"issue":"3","key":"2019111808225102000_B8","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1182\/blood.V61.3.511.bloodjournal613511","article-title":"The ultrastructural localization of immunoglobulin in chronic lymphocytic lymphoma cells: changes in light and heavy chain distribution induced by mitogen stimulation.","volume":"61","author":"Newell","year":"1983","journal-title":"Blood"},{"issue":"1","key":"2019111808225102000_B9","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1182\/blood-2005-05-1923","article-title":"Targeting endoplasmic reticulum protein transport: a novel strategy to kill malignant B cells and overcome fludarabine resistance in CLL.","volume":"107","author":"Carew","year":"2006","journal-title":"Blood"},{"issue":"2","key":"2019111808225102000_B10","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1182\/blood.V62.2.495.bloodjournal622495","article-title":"Differentiation of chronic lymphocytic leukemia cells: correlation between the synthesis and secretion of immunoglobulins and the ultrastructure of the malignant cells.","volume":"62","author":"Rubartelli","year":"1983","journal-title":"Blood"},{"issue":"5","key":"2019111808225102000_B11","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1182\/blood-2003-05-1603","article-title":"Geldanamycin and herbimycin A induce apoptotic killing of B chronic lymphocytic leukemia cells and augment the cells' sensitivity to cytotoxic drugs.","volume":"103","author":"Jones","year":"2004","journal-title":"Blood"},{"issue":"15","key":"2019111808225102000_B12","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.1182\/blood-2010-03-275628","article-title":"Novel targets for endoplasmic reticulum stress-induced apoptosis in B-CLL.","volume":"116","author":"Rosati","year":"2010","journal-title":"Blood"},{"issue":"5","key":"2019111808225102000_B13","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1083\/jcb.201003138","article-title":"Regulation of basal cellular physiology by the homeostatic unfolded protein response.","volume":"189","author":"Rutkowski","year":"2010","journal-title":"J Cell Biol"},{"issue":"6059","key":"2019111808225102000_B14","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1126\/science.1209038","article-title":"The unfolded protein response: from stress pathway to homeostatic regulation.","volume":"334","author":"Walter","year":"2011","journal-title":"Science"},{"issue":"7","key":"2019111808225102000_B15","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/S0092-8674(01)00612-2","article-title":"Complementary signaling pathways regulate the unfolded protein response and are required for C. elegans development.","volume":"107","author":"Shen","year":"2001","journal-title":"Cell"},{"issue":"7","key":"2019111808225102000_B16","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/S0092-8674(01)00611-0","article-title":"XBP1 mRNA is induced by ATF6 and spliced by IRE1 in response to ER stress to produce a highly active transcription factor.","volume":"107","author":"Yoshida","year":"2001","journal-title":"Cell"},{"issue":"6867","key":"2019111808225102000_B17","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/415092a","article-title":"IRE1 couples endoplasmic reticulum load to secretory capacity by processing the XBP-1 mRNA.","volume":"415","author":"Calfon","year":"2002","journal-title":"Nature"},{"issue":"1","key":"2019111808225102000_B18","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.molcel.2007.06.011","article-title":"XBP1 controls diverse cell type- and condition-specific transcriptional regulatory networks.","volume":"27","author":"Acosta-Alvear","year":"2007","journal-title":"Mol Cell"},{"issue":"11","key":"2019111808225102000_B19","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1038\/emboj.2009.117","article-title":"XBP-1 regulates signal transduction, transcription factors and bone marrow colonization in B cells.","volume":"28","author":"Hu","year":"2009","journal-title":"EMBO J"},{"issue":"4","key":"2019111808225102000_B20","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.ccr.2007.02.015","article-title":"The differentiation and stress response factor XBP-1 drives multiple myeloma pathogenesis.","volume":"11","author":"Carrasco","year":"2007","journal-title":"Cancer Cell"},{"issue":"10","key":"2019111808225102000_B21","doi-asserted-by":"crossref","first-page":"6955","DOI":"10.1073\/pnas.102181599","article-title":"Human chronic lymphocytic leukemia modeled in mouse by targeted TCL1 expression.","volume":"99","author":"Bichi","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"2019111808225102000_B22","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/sj.leu.2404017","article-title":"TCL1 shows a regulated expression pattern in chronic lymphocytic leukemia that correlates with molecular subtypes and proliferative state.","volume":"20","author":"Herling","year":"2006","journal-title":"Leukemia"},{"issue":"21","key":"2019111808225102000_B23","doi-asserted-by":"crossref","first-page":"4675","DOI":"10.1182\/blood-2009-03-208256","article-title":"High TCL1 levels are a marker of B-cell receptor pathway responsiveness and adverse outcome in chronic lymphocytic leukemia.","volume":"114","author":"Herling","year":"2009","journal-title":"Blood"},{"issue":"12","key":"2019111808225102000_B24","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.1182\/blood-2008-06-160713","article-title":"PKCbeta is essential for the development of chronic lymphocytic leukemia in the TCL1 transgenic mouse model: validation of PKCbeta as a therapeutic target in chronic lymphocytic leukemia.","volume":"113","author":"Holler","year":"2009","journal-title":"Blood"},{"issue":"31","key":"2019111808225102000_B25","doi-asserted-by":"crossref","first-page":"11713","DOI":"10.1073\/pnas.0604564103","article-title":"B cell receptors in TCL1 transgenic mice resemble those of aggressive, treatment-resistant human chronic lymphocytic leukemia.","volume":"103","author":"Yan","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"2019111808225102000_B26","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1182\/blood-2005-12-011213","article-title":"Characterization of the TCL-1 transgenic mouse as a preclinical drug development tool for human chronic lymphocytic leukemia.","volume":"108","author":"Johnson","year":"2006","journal-title":"Blood"},{"issue":"10","key":"2019111808225102000_B27","doi-asserted-by":"crossref","first-page":"4776","DOI":"10.4049\/jimmunol.160.10.4776","article-title":"Enhanced B-1 cell development, but impaired IgG antibody responses in mice deficient in secreted IgM.","volume":"160","author":"Boes","year":"1998","journal-title":"J Immunol"},{"issue":"7","key":"2019111808225102000_B28","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.1073\/pnas.97.7.3028","article-title":"Tcl1 enhances Akt kinase activity and mediates its nuclear translocation.","volume":"97","author":"Pekarsky","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"2019111808225102000_B29","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1038\/nrc1672","article-title":"The TCL1 family of oncoproteins: co-activators of transformation.","author":"Teitell","year":"2005","journal-title":"Nat Rev Cancer"},{"issue":"7","key":"2019111808225102000_B30","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/ni1357","article-title":"Transcription factor IRF4 controls plasma cell differentiation and class-switch recombination.","volume":"7","author":"Klein","year":"2006","journal-title":"Nat Immunol"},{"issue":"1","key":"2019111808225102000_B31","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/nrc2764","article-title":"From pathogenesis to treatment of chronic lymphocytic leukaemia.","volume":"10","author":"Zenz","year":"2010","journal-title":"Nat Rev Cancer"},{"issue":"6","key":"2019111808225102000_B32","doi-asserted-by":"crossref","first-page":"3690","DOI":"10.4049\/jimmunol.0900953","article-title":"XBP-1-deficient plasmablasts show normal protein folding but altered glycosylation and lipid synthesis.","volume":"183","author":"McGehee","year":"2009","journal-title":"J Immunol"},{"issue":"4","key":"2019111808225102000_B33","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1182\/blood-2010-08-303099","article-title":"Identification of an Ire1alpha endonuclease specific inhibitor with cytotoxic activity against human multiple myeloma.","volume":"117","author":"Papandreou","year":"2011","journal-title":"Blood"},{"issue":"15","key":"2019111808225102000_B34","doi-asserted-by":"crossref","first-page":"E869","DOI":"10.1073\/pnas.1115623109","article-title":"The molecular basis for selective inhibition of unconventional mRNA splicing by an IRE1-binding small molecule.","volume":"109","author":"Cross","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"26","key":"2019111808225102000_B35","doi-asserted-by":"crossref","first-page":"12530","DOI":"10.1073\/pnas.91.26.12530","article-title":"Identification of the TCL1 gene involved in T-cell malignancies.","volume":"91","author":"Virgilio","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"24","key":"2019111808225102000_B36","doi-asserted-by":"crossref","first-page":"11590","DOI":"10.1158\/0008-5472.CAN-06-3613","article-title":"Tcl1 expression in chronic lymphocytic leukemia is regulated by miR-29 and miR-181.","volume":"66","author":"Pekarsky","year":"2006","journal-title":"Cancer Res"},{"issue":"20","key":"2019111808225102000_B37","doi-asserted-by":"crossref","first-page":"6538","DOI":"10.1158\/1078-0432.CCR-08-0476","article-title":"Derlin-1 is overexpressed on the tumor cell surface and enables antibody-mediated tumor targeting therapy.","volume":"14","author":"Ran","year":"2008","journal-title":"Clin Cancer Res"},{"issue":"2","key":"2019111808225102000_B38","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/ng1097-226","article-title":"Deregulation of MUM1\/IRF4 by chromosomal translocation in multiple myeloma.","volume":"17","author":"Iida","year":"1997","journal-title":"Nat Genet"},{"issue":"10","key":"2019111808225102000_B39","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1038\/ng.219","article-title":"A genome-wide association study identifies six susceptibility loci for chronic lymphocytic leukemia.","volume":"40","author":"Di Bernardo","year":"2008","journal-title":"Nat Genet"},{"issue":"4","key":"2019111808225102000_B40","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1038\/leu.2009.298","article-title":"Variant IRF4\/MUM1 associates with CD38 status and treatment-free survival in chronic lymphocytic leukaemia.","volume":"24","author":"Allan","year":"2010","journal-title":"Leukemia"},{"issue":"2","key":"2019111808225102000_B41","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.immuni.2006.07.009","article-title":"Graded expression of interferon regulatory factor-4 coordinates isotype switching with plasma cell differentiation.","volume":"25","author":"Sciammas","year":"2006","journal-title":"Immunity"},{"issue":"7201","key":"2019111808225102000_B42","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/nature07064","article-title":"IRF4 addiction in multiple myeloma.","volume":"454","author":"Shaffer","year":"2008","journal-title":"Nature"},{"issue":"9","key":"2019111808225102000_B43","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1084\/jem.20030275","article-title":"Constitutive expression of AID leads to tumorigenesis.","volume":"197","author":"Okazaki","year":"2003","journal-title":"J Exp Med"},{"issue":"9","key":"2019111808225102000_B44","doi-asserted-by":"crossref","first-page":"3333","DOI":"10.1182\/blood-2003-05-1585","article-title":"Activation-induced cytidine deaminase in chronic lymphocytic leukemia B cells: expression as multiple forms in a dynamic, variably sized fraction of the clone.","volume":"102","author":"Albesiano","year":"2003","journal-title":"Blood"},{"issue":"12","key":"2019111808225102000_B45","doi-asserted-by":"crossref","first-page":"4903","DOI":"10.1182\/blood-2002-09-2906","article-title":"High expression of activation-induced cytidine deaminase (AID) and splice variants is a distinctive feature of poor-prognosis chronic lymphocytic leukemia.","volume":"101","author":"McCarthy","year":"2003","journal-title":"Blood"},{"issue":"7","key":"2019111808225102000_B46","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/nrclinonc.2009.72","article-title":"Molecular and cellular mechanisms of CLL: novel therapeutic approaches.","volume":"6","author":"Pleyer","year":"2009","journal-title":"Nat Rev Clin Oncol"},{"issue":"2","key":"2019111808225102000_B47","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0145-2126(98)00154-4","article-title":"MEC1 and MEC2: two new cell lines derived from B-chronic lymphocytic leukaemia in prolymphocytoid transformation.","volume":"23","author":"Stacchini","year":"1999","journal-title":"Leuk Res"},{"issue":"3","key":"2019111808225102000_B48","first-page":"476","article-title":"Epstein-Barr virus (EBV) can immortalize B-cll cells activated by cytokines.","volume":"8","author":"Wendel-Hansen","year":"1994","journal-title":"Leukemia"},{"issue":"4","key":"2019111808225102000_B49","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1182\/blood-2007-07-100032","article-title":"The LMP1 oncogene of EBV activates PERK and the unfolded protein response to drive its own synthesis.","volume":"111","author":"Lee","year":"2008","journal-title":"Blood"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/120\/5\/1027\/1361976\/zh803112001027.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/120\/5\/1027\/1361976\/zh803112001027.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,23]],"date-time":"2023-06-23T09:41:41Z","timestamp":1687513301000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/120\/5\/1027\/30270\/Overexpression-of-TCL1-activates-the-endoplasmic"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8,2]]},"references-count":49,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,8,2]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2011-11-394346","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,8,2]]}}}